about
Lymphocyte activation gene 3 and coronary artery diseaseCurcumin combined with FAPαc vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in melanoma.The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures.Update on Metastatic Uveal Melanoma: Progress and Challenges.Focus on cutaneous and uveal melanoma specificities.Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.Prognostic value of PD -L1 expression in patients with primary solid tumors.Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.
P2860
Q30275618-FE7FB81C-0A4C-486E-9FB3-B41DA198F490Q36413332-391BB75F-954C-4CD3-A8D6-089DAA1BCABEQ37046786-8D987BC1-2F0F-4C58-A8C3-CF739A760A89Q38783505-E857B303-A4A5-48C8-B103-AB6B5F0EC1F3Q39312161-CC3DE01F-EAD6-4670-81CA-44CA92B57D6DQ47134535-FF6062F8-3064-4E5A-9E3B-DF6DCBC14C03Q49732572-EA91B596-F426-4091-9CF1-67521507679FQ55278851-315839DA-1247-4583-B877-8A55E1183199
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
PD-1 and PD-L1 antibodies for melanoma
@ast
PD-1 and PD-L1 antibodies for melanoma
@en
PD-1 and PD-L1 antibodies for melanoma
@nl
type
label
PD-1 and PD-L1 antibodies for melanoma
@ast
PD-1 and PD-L1 antibodies for melanoma
@en
PD-1 and PD-L1 antibodies for melanoma
@nl
prefLabel
PD-1 and PD-L1 antibodies for melanoma
@ast
PD-1 and PD-L1 antibodies for melanoma
@en
PD-1 and PD-L1 antibodies for melanoma
@nl
P2860
P1476
PD-1 and PD-L1 antibodies for melanoma
@en
P2093
Inés Zarzoso
Katy K Tsai
P2860
P304
P356
10.4161/21645515.2014.983409
P407
P50
P577
2014-01-01T00:00:00Z